Finding the Optimal Resistance Training Exercise for type 2 diabetes

ISRCTN ISRCTN97865321
DOI https://doi.org/10.1186/ISRCTN97865321
Secondary identifying numbers #19581
Submission date
14/01/2010
Registration date
21/06/2010
Last edited
21/06/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Dr Paul Oh
Scientific

Toronto Rehabilitation Institute
347 Rumsey Rd
Toronto
M4G 1R7
Canada

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleFinding the optimal volume and intensity of resistance training exercise for type 2 diabetes: a randomised controlled trial
Study acronymThe FORTE Study
Study hypothesisA higher intensity, hypertrophic resistance training protocol added to aerobic training would lead to more marked improvements to glycaemic control and cardiovascular risk factors compared to lower intensity endurance training.
Ethics approval(s)University of Toronto Research Ethics Board (REB) approved in February 2006 (ref: 19581)
ConditionType 2 diabetes
InterventionSix months of aerobic and resistance training:
1. Aerobic training and minimal resistance training (usual care)
2. Aerobic training and high intensity resistance training
3. Aerobic training and low intensity resistance training

The intervention for all groups was 6 months. Following completion of the program, patients will not be followed-up.
Intervention typeOther
Primary outcome measureMeasured at baseline and 6 months:
1. HbA1c
2. Maximal aerobic power (VO2 max)
Secondary outcome measuresMeasured at baseline and 6 months:
1. Fasting glucose
2. Insulin
3. Proinsulin
4. Blood lipid profile
5. Body composition (dual energy x-ray absorptiometry [DEXA])
6. Cytokines (interleukin-6 [IL-6], interleukin-1B [IL-1B], c-reactive protein [CRP])
7. Adipokines (tumour necrotising factor-alpha [TNF-alpha], adiponectin, leptin, leptin receptor)
8. Depressive mood (Center for Epidemiologic Studies Depression Scale [CESD])
9. Quality of life (Diabetes Quality of Life Clinical Trial Questionnaire [DSQLQ])
10. Nutrition intake
Overall study start date01/05/2006
Overall study end date31/03/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants120
Participant inclusion criteria1. Adults aged greater than 18 years, either sex
2. Type 2 Diabetes
3. Participating in the Diabetes Exercise and Healthy Lifestyle Program of the Toronto Rehabilitation Institute
Participant exclusion criteria1. History of diagnosed cardiovascular disease
2. Contraindications to high intensity exercise participation:
2.1. Glaucoma
2.2. Retinopathy
2.3. Musculoskeletal limitations
2.4. Kidney disease
2.5. Balance impairments
Recruitment start date01/05/2006
Recruitment end date31/03/2009

Locations

Countries of recruitment

  • Canada

Study participating centre

Toronto Rehabilitation Institute
Toronto
M4G 1R7
Canada

Sponsor information

Toronto Rehabilitation Institute (Canada)
Research organisation

c/o Paul Oh, MD
347 Rumsey Road
Toronto
M4G 1R7
Canada

Phone 1 416 597 3422
Email oh.pauldr@torontorehab.on.ca
Website http://www.torontorehab.on.ca/
ROR logo "ROR" https://ror.org/00mxe0976

Funders

Funder type

Research organisation

Toronto Rehabilitation Institute (Canada)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Toronto Rehab, UHN Toronto Rehabilitation Institute, TRI
Location
Canada
Human Physiology Performance Laboratory (Canada)

No information available

Canadian Diabetes Association (Canada)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan